21.8 C
New York
Monday, June 15, 2026

Tag: presentations

newssourceFORcompanyinformationcontent1marketreleases

ORVANA ANNOUNCES ATTENDANCE AT THE MINING INVESTMENT EVENT IN QUEBEC CITY, CANADA

TSX:ORVOTCQX: ORVMFTORONTO, June 2, 2026 /PRNewswire/ -- Orvana Minerals Corp. (TSX: ORV) (OTCQX: ORVMF) ("Orvana" or the "Company") is pleased to announce that Mr. Raúl...

ORVANA ANNOUNCES ATTENDANCE AT THE MINING INVESTMENT EVENT IN QUEBEC CITY, CANADA

TSX:ORVOTCQX: ORVMFTORONTO, June 1, 2026 /PRNewswire/ - Orvana Minerals Corp. (TSX: ORV) (OTCQX: ORVMF) ("Orvana" or the "Company") is pleased to announce that Mr. Raúl...

ORVANA ANNOUNCES ATTENDANCE AT THE MINING INVESTMENT EVENT IN QUEBEC CITY, CANADA

TSX:ORVOTCQX: ORVMFTORONTO, June 1, 2026 /CNW/ - Orvana Minerals Corp. (TSX: ORV) (OTCQX: ORVMF) ("Orvana" or the "Company") is pleased to announce that Mr. Raúl...

ROLLINS TO PRESENT AT UPCOMING INVESTOR CONFERENCES

ATLANTA, June 1, 2026 /PRNewswire/ -- Rollins, Inc. (NYSE: ROL), a premier global consumer and commercial services company, today announced that members of management...

InterDigital to Share 6G Leadership, Potential for ISAC and Agentic AI at EuCNC & 6G Summit

At EuCNC, InterDigital will demonstrate 6G leadership in AI, ISAC, and collaborative sensing for 6G verticals, part of the SNS-JU MultiX project

CelHive: The Rising Unicorn Transforming the Future of AI Workforces

Revolutionary AI platform achieves 200,000 users milestone, showcasing unprecedented growth in the booming AI agent technology sector 
Revolutionary AI platform achieves 200,000 users milestone, showcasing unprecedented growth in the booming AI agent technology sector

Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years

AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Continued progress across pipeline programs with focus on pancreatic cancer

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis

PAPZIMEOS approval marks a historic milestone for the RRP patient community as the first and only FDA-approved therapy for the treatment of adults with...

Malibu Boats, Inc. Announces Earnings Release Date and Conference Call Information for Fourth Quarter and Full-Year Fiscal 2025 Financial Results

LOUDON, Tenn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Malibu Boats, Inc. (Nasdaq: MBUU) announced today that it will release its fourth quarter and full-year fiscal 2025 financial results on Thursday, August 28, 2025, before the market opens. Following the release, the company’s management will host a conference call to discuss the results at 8:30 a.m. Eastern Time on the same day.

G Mining Ventures Reports Strong Q2 2025 Results

BROSSARD, QC, Aug. 14, 2025 /PRNewswire/ - G Mining Ventures Corp. ("GMIN" or the "Corporation") (TSX: GMIN) (OTCQX: GMINF) is pleased to report its...

O-RAN ALLIANCE Opens Call for Participation in its O-RAN Global PlugFest Fall 2025

Call for Participation for the O-RAN ALLIANCE Global PlugFest Fall 2025 is underwayThe PlugFest is hosted by 25 operators and independent institutions in 19...

O-RAN ALLIANCE Opens Call for Participation in its O-RAN Global PlugFest Fall 2025

Call for Participation for the O-RAN ALLIANCE Global PlugFest Fall 2025 is underwayThe PlugFest is hosted by 25 operators and independent institutions in 19...

O-RAN ALLIANCE Opens Call for Participation in its O-RAN Global PlugFest Fall 2025

Call for Participation for the O-RAN ALLIANCE Global PlugFest Fall 2025 is underwayThe PlugFest is hosted by 25 operators and independent institutions in 19...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPresentations

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers